Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,208 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS

NCT05180942

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +14 more
Locations: Nepean Hospital Kingswood, New South Wales, Australia

Calvary Mater Newcastle Waratah, New South Wales, Australia

Bundaberg Base Hospital Bundaberg, Queensland, Australia

Hervey Bay Hospital Hervey Bay, Queensland, Australia

View Trial Details

Recruiting

A Study of ST-1898 for Unresectable or Metastatic Melanoma

NCT06359860

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Peking University Cancer Hospital & Institute Beijing, China

View Trial Details

Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +79 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Ironwood Cancer & Research Centers Chandler, Arizona, United States

Genesis Cancer Center Hot Springs, Arkansas, United States

University of California, San Diego La Jolla, California, United States

View all 57 locations

View Trial Details

Recruiting

Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade

NCT07130032

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: EuroCityClinic LLC Saint Petersburg, Sankt-Peterburg, Russia

View Trial Details

Recruiting

Pan-tumor MRD Study

NCT06605404

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations: Medical Oncology Associates of San Diego San Diego, California, United States

Taylor Cancer Research Center Maumee, Ohio, United States

View Trial Details

Recruiting

Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma

NCT03646617

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Lancaster General Hospital Lancaster, Pennsylvania, United States

Abramson Cancer Center Philadelphia, Pennsylvania, United States

Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

NCT06754904

Conditions: Melanoma, Melanoma, Skin, Neoplasms, +10 more
Locations: Erasmus MC Rotterdam, South Holland, Netherlands

View Trial Details

Recruiting

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

NCT04572451

Conditions: Antineoplastic Agents, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, +15 more
Locations: University of Chicago Medical Center Chicago, Illinois, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

OH2 Injection in Solid Tumors

NCT04386967

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

OH2 Injection in Melanoma

NCT05868707

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

Fujian Cancer Hosptial Fuzhou, Fujian, China

Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China

View all 30 locations

View Trial Details